Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children.

Pascal M, Konstantinou GN, Masilamani M, Lieberman J, Sampson HA.

Clin Exp Allergy. 2013 Jan;43(1):116-27. doi: 10.1111/cea.12014.

PMID:
23278886
2.

Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic.

Prickett SR, Voskamp AL, Phan T, Dacumos-Hill A, Mannering SI, Rolland JM, O'Hehir RE.

Clin Exp Allergy. 2013 Jun;43(6):684-97. doi: 10.1111/cea.12113.

3.

Peanut T-cell epitope discovery: Ara h 1.

Ramesh M, Yuenyongviwat A, Konstantinou GN, Lieberman J, Pascal M, Masilamani M, Sampson HA.

J Allergy Clin Immunol. 2016 Jun;137(6):1764-1771.e4. doi: 10.1016/j.jaci.2015.12.1327. Epub 2016 Mar 4.

PMID:
26953158
4.

Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2.

Glaspole IN, de Leon MP, Rolland JM, O'Hehir RE.

Allergy. 2005 Jan;60(1):35-40.

5.

Walnut allergy in peanut-allergic patients: significance of sequential epitopes of walnut homologous to linear epitopes of Ara h 1, 2 and 3 in relation to clinical reactivity.

Rosenfeld L, Shreffler W, Bardina L, Niggemann B, Wahn U, Sampson HA, Beyer K.

Int Arch Allergy Immunol. 2012;157(3):238-45. doi: 10.1159/000327841. Epub 2011 Oct 27.

PMID:
22042002
6.
7.

Ara h 1-reactive T cells in individuals with peanut allergy.

DeLong JH, Simpson KH, Wambre E, James EA, Robinson D, Kwok WW.

J Allergy Clin Immunol. 2011 May;127(5):1211-8.e3. doi: 10.1016/j.jaci.2011.02.028. Epub 2011 Apr 2.

8.

Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.

Anzengruber J, Bublin M, Bönisch E, Janesch B, Tscheppe A, Braun ML, Varga EM, Hafner C, Breiteneder H, Schäffer C.

Mol Immunol. 2017 May;85:81-88. doi: 10.1016/j.molimm.2017.02.005. Epub 2017 Feb 14.

9.

Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.

Wisniewski JA, Commins SP, Agrawal R, Hulse KE, Yu MD, Cronin J, Heymann PW, Pomes A, Platts-Mills TA, Workman L, Woodfolk JA.

Clin Exp Allergy. 2015 Jul;45(7):1201-13. doi: 10.1111/cea.12537.

10.

Allergenicity of peanut component Ara h 2: Contribution of conformational versus linear hydroxyproline-containing epitopes.

Bernard H, Guillon B, Drumare MF, Paty E, Dreskin SC, Wal JM, Adel-Patient K, Hazebrouck S.

J Allergy Clin Immunol. 2015 May;135(5):1267-74.e1-8. doi: 10.1016/j.jaci.2014.10.025. Epub 2014 Dec 4.

PMID:
25483599
11.

IgE epitopes of intact and digested Ara h 1: a comparative study in humans and rats.

Bøgh KL, Nielsen H, Madsen CB, Mills EN, Rigby N, Eiwegger T, Szépfalusi Z, Roggen EL.

Mol Immunol. 2012 Jul;51(3-4):337-46. doi: 10.1016/j.molimm.2012.04.002. Epub 2012 May 1.

PMID:
22555070
12.

An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.

Starkl P, Felix F, Krishnamurthy D, Stremnitzer C, Roth-Walter F, Prickett SR, Voskamp AL, Willensdorfer A, Szalai K, Weichselbaumer M, O'Hehir RE, Jensen-Jarolim E.

Clin Exp Allergy. 2012 Dec;42(12):1801-12. doi: 10.1111/cea.12031.

PMID:
23181796
13.

Isoforms of the major peanut allergen Ara h 2: IgE binding in children with peanut allergy.

Hales BJ, Bosco A, Mills KL, Hazell LA, Loh R, Holt PG, Thomas WR.

Int Arch Allergy Immunol. 2004 Oct;135(2):101-7. Epub 2004 Sep 2.

PMID:
15345908
14.

IgE versus IgG4 epitopes of the peanut allergen Ara h 1 in patients with severe allergy.

Bøgh KL, Nielsen H, Eiwegger T, Madsen CB, Mills EN, Rigby NM, Szépfalusi Z, Roggen EL.

Mol Immunol. 2014 Apr;58(2):169-76. doi: 10.1016/j.molimm.2013.11.014. Epub 2013 Dec 22.

PMID:
24365751
15.

Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes.

Shreffler WG, Beyer K, Chu TH, Burks AW, Sampson HA.

J Allergy Clin Immunol. 2004 Apr;113(4):776-82.

PMID:
15100687
16.

Ara h 2: crystal structure and IgE binding distinguish two subpopulations of peanut allergic patients by epitope diversity.

Mueller GA, Gosavi RA, Pomés A, Wünschmann S, Moon AF, London RE, Pedersen LC.

Allergy. 2011 Jul;66(7):878-85. doi: 10.1111/j.1398-9995.2010.02532.x. Epub 2011 Jan 21.

17.

IgE binding to peanut components by four different techniques: Ara h 2 is the most relevant in peanut allergic children and adults.

Klemans RJ, Liu X, Knulst AC, Knol MJ, Gmelig-Meyling F, Borst E, Pasmans SG, Knol EF.

Clin Exp Allergy. 2013 Aug;43(8):967-74. doi: 10.1111/cea.12136.

PMID:
23889250
18.
19.

Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors.

Blanc F, Adel-Patient K, Drumare MF, Paty E, Wal JM, Bernard H.

Clin Exp Allergy. 2009 Aug;39(8):1277-85. doi: 10.1111/j.1365-2222.2009.03294.x. Epub 2009 Jun 15.

PMID:
19538351
20.

The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model.

Klemans RJ, Otte D, Knol M, Knol EF, Meijer Y, Gmelig-Meyling FH, Bruijnzeel-Koomen CA, Knulst AC, Pasmans SG.

J Allergy Clin Immunol. 2013 Jan;131(1):157-63. doi: 10.1016/j.jaci.2012.08.010. Epub 2012 Sep 29.

PMID:
23026497

Supplemental Content

Support Center